查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
噬菌体疗法的全球市场 - 产业规模，占有率，趋势，机会，预测:各细菌类型，各产品，各用途，各地区(2017年～2027年)
市场调查报告书
商品编码
1166586

噬菌体疗法的全球市场 - 产业规模，占有率，趋势，机会，预测:各细菌类型，各产品，各用途，各地区(2017年～2027年)

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type, By Product, By Application, and By Region
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球噬菌体疗法市场，预计从2023年到2027年的预测期间内完成惊人的成长。主要原因，是经由食物传染疾病的发生率增加，抗生素的感染疾病，广泛的研究开发等。支撑市场成长的其他因素，为食品、饮料产业上噬菌体的用途扩大，政府投资增加，在大众之间的意识高涨，技术的进步。

本报告提供全球噬菌体疗法市场相关调查，各市场区隔分析，市场动态，企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 摘要整理

第4章 COVID-19对全球噬菌体疗法市场的影响

第5章 VOC (客户的迴响)

第6章 临床试验分析

第7章 全球噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型(沙门菌，噬菌体，链球菌，大肠菌，其他)
    • 各产品(口服的摄取，外性摄取，外科的治疗)
    • 各用途(人医学，兽医学，食品、饮料，其他)
    • 各企业(2021年)
    • 各地区
  • 市场地图

第8章 北美的噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型
    • 各产品
    • 各用途
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第9章 欧洲的噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型
    • 各产品
    • 各用途
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第10章 亚太地区的噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型
    • 各产品
    • 各用途
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第11章 南美的噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型
    • 各产品
    • 各用途
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第12章 中东、非洲的噬菌体疗法市场预测

  • 市场规模与预测
    • 各金额
  • 市场占有率与预测
    • 各细菌类型
    • 各产品
    • 各用途
    • 各国
  • 中东、非洲:各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 埃及
    • 土耳其

第13章 市场动态

  • 促进因素
  • 课题

第14章 市场趋势与发展

第15章 竞争情形

  • Armata Pharmaceuticals, Inc.
  • iNtODEWORLD, Inc.
  • Phage International, Inc.
  • Fixed-Phage Limited
  • OCUS BIOSCIENCES, INC.
  • Intralytix, Inc
  • PhagoMed Biopharma GmbH
  • PHAGELUX, INC.
  • Pherecydes Pharma SADIR
  • Adaptive Phage Therapeutics Inc.

第16章 策略性建议

简介目录
Product Code: 12984

The global phage therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of foodborne diseases, anti-biotic infections, and extensive research and development. Phages, also known as bacteriophages, are viruses that only kill and selectively target bacteria. They are the most common biological entities found in nature, effectively fighting, and destroying multi-drug-resistant bacteria. They are used to treat or stop bacterial infections in patients' bodies. The other factors supporting the market's growth are, the increasing application of bacteriophage across the food and beverage industry, increasing government investments, rising awareness among the masses, and technological advancements.

High Prevalence Rate of Foodborne Diseases and Anti-Biotic Infections

The rise in the prevalence rate of foodborne diseases and anti-biotic infections across the globe is expected to enhance the market's growth. Foodborne infections are caused by rotten food, as pathogenic bacteria and viruses are present in them. Bacteriophages are extremely specific to target bacteria. Its usage targets a specific bacterial species and significantly reduces off-target effects on the microbiome or human patient, as bacteriophages do not directly affect human cells. According to the WHO, in 2019, forecasted that about 600 million people will become ill and 420,000 will die because of contaminated food resulting in the loss of 33 million healthy life years. Also, according to the Centers for Disease Control and Prevention (CDC), in 2019, approximately 2 million people in the United States will contract an antibiotic-resistant infection, with at least 23,000 people dying every year.

Increasing Investment

Heavy investments to support phage therapy by the government is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government and lead companies across the globe are investing in clinical trials and R&D Activities, which is propelling the growth of the market. For instance, in 2016, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, was granted US$ 5 Mn for 24 research projects to develop advanced therapies such as bacteriophage therapy and others for the treatment of bacterial infections.

Emergence of e-Commerce

Emergence of e-Commerce is bolstering the growth of the market. Several biotech market players are starting to set up online pharmacies of bacteriophage preparations to make phages and phage therapies available across the globe. For instance, in 2020, Ridgeway, a Digital agency, launched a new e-Commerce website for Optibac probiotics, to build on customer compliance and repeat purchase of phage therapy supplements.

Market Segmentation

The global phage therapy market is segmented into bacteria type, products, application, and company. Based on bacteria type, the market is divided into salmonella, bacteriophage, streptococcus, E.coli, and others. Based on products, the market is divided into oral consumption, external consumption, and surgical treatment. Based on application, the market is segmented into human medicines, veterinary sciences, food & beverage, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of foodborne diseases and anti-biotic infections in the country.

Market Players

Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are some of the leading companies operating in the market.

Report Scope:

In this report, global phage therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Phage Therapy Market, By Bacterial Type:

Salmonella

Bacteriophage

Streptococcus

E.Coli

Others

  • Phage Therapy Market, By Products:

Oral Consumption

External Consumption

Surgical Treatment

  • Phage Therapy Market, By Application:

Human Medicines

Veterinary Sciences

Food & Beverage

Others

  • Phage Therapy Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Phage Therapy Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Phage Therapy Market

5. Voice of Customer

6. Clinical Trials Analysis

7. Global Phage Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others)
    • 7.2.2. By Product (Oral Consumption, External Consumption, Surgical Treatment)
    • 7.2.3. By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others)
    • 7.2.4. By Company (2021)
    • 7.2.5. By Region
  • 7.3. Market Map

8. North America Phage Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Bacteria Type
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Phage Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Bacteria Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. Mexico Phage Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Bacteria Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Canada Phage Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Bacteria Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application

9. Europe Phage Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Bacteria Type
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Phage Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Bacteria Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. Germany Phage Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Bacteria Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. United Kingdom Phage Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Bacteria Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application
    • 9.3.4. Italy Phage Therapy Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Bacteria Type
        • 9.3.4.2.2. By Product
        • 9.3.4.2.3. By Application
    • 9.3.5. Spain Phage Therapy Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Bacteria Type
        • 9.3.5.2.2. By Product
        • 9.3.5.2.3. By Application

10. Asia-Pacific Phage Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Bacteria Type
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. Asia-Pacific: Country Analysis
    • 10.3.1. China Phage Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Bacteria Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. India Phage Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Bacteria Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
    • 10.3.3. Japan Phage Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Bacteria Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application
    • 10.3.4. South Korea Phage Therapy Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Bacteria Type
        • 10.3.4.2.2. By Product
        • 10.3.4.2.3. By Application
    • 10.3.5. Australia Phage Therapy Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Bacteria Type
        • 10.3.5.2.2. By Product
        • 10.3.5.2.3. By Application

11. South America Phage Therapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Bacteria Type
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Phage Therapy Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Bacteria Type
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By Application
    • 11.3.2. Argentina Phage Therapy Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Bacteria Type
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By Application
    • 11.3.3. Colombia Phage Therapy Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Bacteria Type
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By Application

12. Middle East and Africa Phage Therapy Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Bacteria Type
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Phage Therapy Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Bacteria Type
        • 12.3.1.2.2. By Product
        • 12.3.1.2.3. By Application
    • 12.3.2. Saudi Arabia Phage Therapy Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Bacteria Type
        • 12.3.2.2.2. By Product
        • 12.3.2.2.3. By Application
    • 12.3.3. UAE Phage Therapy Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Bacteria Type
        • 12.3.3.2.2. By Product
        • 12.3.3.2.3. By Application
    • 12.3.4. Egypt Phage Therapy Market Outlook
      • 12.3.4.1. Market Size & Forecast
        • 12.3.4.1.1. By Value
      • 12.3.4.2. Market Share & Forecast
        • 12.3.4.2.1. By Bacteria Type
        • 12.3.4.2.2. By Product
        • 12.3.4.2.3. By Application
    • 12.3.5. Turkey Phage Therapy Market Outlook
      • 12.3.5.1. Market Size & Forecast
        • 12.3.5.1.1. By Value
      • 12.3.5.2. Market Share & Forecast
        • 12.3.5.2.1. By Bacteria Type
        • 12.3.5.2.2. By Product
        • 12.3.5.2.3. By Application

13. Market Dynamics

  • 13.1. Drivers
  • 13.2. Challenges

14. Market Trends & Developments

15. Competitive Landscape

  • 15.1. Armata Pharmaceuticals, Inc.
  • 15.2. iNtODEWORLD, Inc.
  • 15.3. Phage International, Inc.
  • 15.4. Fixed-Phage Limited
  • 15.5. OCUS BIOSCIENCES, INC.
  • 15.6. Intralytix, Inc
  • 15.7. PhagoMed Biopharma GmbH
  • 15.8. PHAGELUX, INC.
  • 15.9. Pherecydes Pharma SADIR
  • 15.10. Adaptive Phage Therapeutics Inc.

16. Strategic Recommendations